Increased severe primary graft dysfunction in left ventricular assist device patients following united network for

Aaron Guo1, Kunal Kotkar1, Brandon Jocher1

  • 1Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Clinical Transplantation
|November 6, 2022
PubMed

Insights

The 2018 UNOS heart allocation changes increased severe primary graft dysfunction in LVAD patients. Blood transfusions were linked to severe PGD, highlighting the need for careful management in heart transplant recipients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Device Technology

Background:

  • The United Network for Organ Sharing (UNOS) updated its heart allocation system in 2018, prioritizing patients on temporary support and those with complications on a left-ventricular assist device (LVAD).
  • These policy changes may affect outcomes for patients bridged to heart transplantation using an LVAD.

Purpose of the Study:

  • To evaluate the impact of the 2018 UNOS heart allocation system changes on post-transplant outcomes.
  • Specifically, to assess changes in severe primary graft dysfunction (PGD) and other outcomes in heart transplant recipients before and after the policy implementation.

Main Methods:

  • A retrospective study was conducted on 168 adult heart transplant recipients between 2016 and 2020.
  • Data were collected from chart reviews and national databases, comparing outcomes before and after the UNOS allocation policy change.
  • Primary outcome was severe PGD; secondary outcomes included 30-day readmission, 30-day mortality, and 1-year mortality.

Main Results:

  • Overall incidence of severe PGD remained similar (10% vs. 15%, p=0.3).
  • However, severe PGD significantly increased in the LVAD-bridged cohort (12% vs. 40%, p<0.01).
  • Blood transfusion emerged as a predictor of severe PGD (OR 1.3, p<0.01).

Conclusions:

  • The updated UNOS heart allocation system led to a notable increase in severe PGD among LVAD-bridged heart transplant recipients.
  • While overall readmission and survival rates were unaffected, the findings underscore the vulnerability of LVAD patients post-transplant under the new system.
  • Blood transfusions should be carefully managed in this population to mitigate PGD risk.
Abstract

Related Concept Videos